Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Kookminbio Corp. operates a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The portfolio presently features 1 pending office action. This activity is confined to 1 distinct art unit and involves 1 distinct examiner, reflecting a streamlined prosecution profile at this stage. The presence of 1 distinct art unit suggests a focused set of active negotiations with the patent office for the company.
KARUNASENA, ENUSHA is the busiest examiner for the portfolio, managing 1 pending office action. This 1 pending office action represents the total volume of active matters for Kookminbio Corp. Because the portfolio interacts with only 1 distinct examiner, the immediate outcomes are subject to the specific examination patterns of KARUNASENA, ENUSHA. The concentration of the pending workload under this examiner further simplifies the technical landscape for these pending matters and requires a targeted legal strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KARUNASENA, ENUSHA | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18489830 | MICROBIOME COMPOSITION OF HALOPHILIC BACILLUS VELEZENSIS KMU01 STRAIN FERMENTED CULTURE SUPERNATANT WITH ANTI-OBESITY EFFECT | KARUNASENA, ENUSHA | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18489830 | MICROBIOME COMPOSITION OF HALOPHILIC BACILLUS VELEZENSIS KMU01 STRAIN FERMENTED CULTURE SUPERNATANT WITH ANTI-OBESITY EFFECT | KARUNASENA, ENUSHA | 1653 | §101§102 | Non-Final OA | — | Pending | Oct 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial